These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 19907328

  • 1. The significance of C4d staining with minimal histologic abnormalities.
    Haas M.
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [Abstract] [Full Text] [Related]

  • 2. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.
    Clin Transplant; 2008 Feb; 22(1):61-7. PubMed ID: 18217907
    [Abstract] [Full Text] [Related]

  • 3. Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection.
    Onitsuka S, Yamaguchi Y, Tanabe K, Takahashi K, Toma H.
    Clin Transplant; 1999 Feb; 13 Suppl 1():33-7. PubMed ID: 10751054
    [Abstract] [Full Text] [Related]

  • 4. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.
    Clin Transplant; 2007 Feb; 21(2):159-65. PubMed ID: 17425739
    [Abstract] [Full Text] [Related]

  • 5. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.
    Imai N, Nishi S, Alchi B, Ueno M, Fukase S, Arakawa M, Saito K, Takahashi K, Gejyo F.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2589-95. PubMed ID: 16644773
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
    Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.
    J Am Soc Nephrol; 2009 Jan; 20(1):197-204. PubMed ID: 18776120
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
    Yoon HE, Kim SH, Kim JY, Oh EJ, Park SC, Choi BS, Choi YJ, Moon IS, Kim YS, Yang CW.
    Clin Transplant; 2009 Jan; 23(6):812-8. PubMed ID: 19191803
    [Abstract] [Full Text] [Related]

  • 12. Incidence and importance of c4d deposition in renal allograft dysfunction.
    Demirci C, Sen S, Sezak M, Sarsik B, Hoşcoşkun C, Töz H.
    Transplant Proc; 2008 Jan; 40(1):174-7. PubMed ID: 18261578
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T.
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [Abstract] [Full Text] [Related]

  • 16. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

  • 17. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation.
    Kato M, Morozumi K, Takeuchi O, Oikawa T, Koyama K, Usami T, Shimano Y, Ito A, Horike K, Otsuka Y, Toda S, Takeda A, Uchida K, Haba T, Kimura G.
    Transplantation; 2003 Mar 15; 75(5):663-5. PubMed ID: 12640306
    [Abstract] [Full Text] [Related]

  • 18. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K.
    Nephrol Dial Transplant; 2008 May 15; 23(5):1735-41. PubMed ID: 18065805
    [Abstract] [Full Text] [Related]

  • 19. Glomerular fibrin thrombi in ABO and crossmatch compatible renal allograft biopsies.
    Troxell ML, Norman D, Mittalhenkle A.
    Pathol Res Pract; 2011 Jan 15; 207(1):15-23. PubMed ID: 21067871
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.